A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma.
Haematologica(2024)
摘要
Not available.
更多查看译文
关键词
continuous dose lenalidomide,hodgkin lymphoma
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要